| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 25,165 | 24,531 | 23,060 | 20,917 | | Cost of Revenue | 11,836 | 14,900 | 12,969 | 12,581 | | | Gross Profit | 13,329 | 9,631 | 10,091 | 8,336 | | | Operating Expenses | | Research Development | 2,444 | 2,575 | 2,425 | 2,217 | | Selling General and Administrative | 11,561 | 11,358 | 11,270 | 12,097 | | Non Recurring | 1,168 |
-
|
-
| (1,859) | | Others |
-
| 1,240 | 714 | 3,235 | | | | Total Operating Expenses |
-
|
-
|
-
| 15,690 | | | | Operating Income or Loss | (1,863) | (5,542) | (4,318) | (7,354) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (49) | 90 | 92 | (213) | | Earnings Before Interest And Taxes | (1,893) | (5,452) | (4,226) | (7,567) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,893) | (5,452) | (4,226) | (7,567) | | Income Tax Expense | (79) | (173) | 17 | 105 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,814) | (5,279) | (4,243) | (7,672) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,814) | (5,279) | (4,243) | (7,672) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,814) | ($5,279) | ($4,243) | ($7,672) |
|
0.51% Nasdaq 
Income Statement
